Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ronconi

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Journal of Biological Regulators and Homeostatic Agents|July 7, 2021
Neurohormonal markers in chronic rhinosinusitisR A Compton, A R Lonergan, I Tsillioni, et al.
Journal of Biological Regulators and Homeostatic Agents|June 21, 2018
New concepts in neuroinflammation: mast cells pro-inflammatory and anti-inflammatory cytokine mediatorsAl Caraffa, C Conti, C D Ovidio, et al.
Journal of Biological Regulators and Homeostatic Agents|September 23, 2016
ENOX2 (or tNOX): a new and old molecule with cancer activity involved in tumor prevention and therapyG Ronconi, G Lessiani, E Spinas, et al.
Journal of Biological Regulators and Homeostatic Agents|July 27, 2019
Mesenchymal stem cells and IL-37: a powerful combinationA Gugliandolo, A L Caraffa, C E Gallenga, et al.
European Journal of Physical and Rehabilitation Medicine|July 24, 2012
Role of spiritual beliefs on disability and health-related quality of life in acute inpatient rehabilitation unitL Maggi, P E Ferrara, I Aprile, et al.
Journal of Biological Regulators and Homeostatic Agents|April 4, 2019
Gut microbiota and immunity in common variable immunodeficiency: crosstalk with pro-inflammatory cytokinesL Franza, V Carusi, S Altamura, et al.
Journal of Biological Regulators and Homeostatic Agents|April 25, 2018
Low-grade chronic inflammation mediated by mast cells in fibromyalgia: role of IL-37F Mastrangelo, I Frydas, G Ronconi, et al.
Journal of Biological Regulators and Homeostatic Agents|December 30, 2020
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problemP Conti, Al Caraffa, C E Gallenga, et al.
Journal of Biological Regulators and Homeostatic Agents|September 18, 2020
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19P Conti, Al Caraffa, G Tetè, et al.
Journal of Biological Regulators and Homeostatic Agents|August 4, 2020
IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra)P Conti, Al Caraffa, C E Gallenga, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Journal of Biological Regulators and Homeostatic Agents|July 7, 2021
Neurohormonal markers in chronic rhinosinusitisR A Compton, A R Lonergan, I Tsillioni, et al.
Journal of Biological Regulators and Homeostatic Agents|June 21, 2018
New concepts in neuroinflammation: mast cells pro-inflammatory and anti-inflammatory cytokine mediatorsAl Caraffa, C Conti, C D Ovidio, et al.
Journal of Biological Regulators and Homeostatic Agents|September 23, 2016
ENOX2 (or tNOX): a new and old molecule with cancer activity involved in tumor prevention and therapyG Ronconi, G Lessiani, E Spinas, et al.
Journal of Biological Regulators and Homeostatic Agents|July 27, 2019
Mesenchymal stem cells and IL-37: a powerful combinationA Gugliandolo, A L Caraffa, C E Gallenga, et al.
European Journal of Physical and Rehabilitation Medicine|July 24, 2012
Role of spiritual beliefs on disability and health-related quality of life in acute inpatient rehabilitation unitL Maggi, P E Ferrara, I Aprile, et al.
Journal of Biological Regulators and Homeostatic Agents|April 4, 2019
Gut microbiota and immunity in common variable immunodeficiency: crosstalk with pro-inflammatory cytokinesL Franza, V Carusi, S Altamura, et al.
Journal of Biological Regulators and Homeostatic Agents|April 25, 2018
Low-grade chronic inflammation mediated by mast cells in fibromyalgia: role of IL-37F Mastrangelo, I Frydas, G Ronconi, et al.
Journal of Biological Regulators and Homeostatic Agents|December 30, 2020
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problemP Conti, Al Caraffa, C E Gallenga, et al.
Journal of Biological Regulators and Homeostatic Agents|September 18, 2020
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19P Conti, Al Caraffa, G Tetè, et al.
Journal of Biological Regulators and Homeostatic Agents|August 4, 2020
IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra)P Conti, Al Caraffa, C E Gallenga, et al.
Pageof 7